Full Text View
Tabular View
No Study Results Posted
Related Studies
Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
This study is ongoing, but not recruiting participants.
Study NCT00032279   Information provided by Facet Biotech
First Received: March 14, 2002   Last Updated:   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graft-vs-Host Disease
Additional conditions recognized in this trial
Graft vs Host Disease
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
Visilizumab
Additional drug interventions recognized in this trial
Glucocorticoids
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Fred Hutchinson Cancer Research Center
Facet Biotech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services